Mereo BioPharma MREO
NASDAQ MREO
$0.29 0.00 (-1.32%)
At close: Oct 21, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Debt Ratio (2017 - 2024)

Updated

Mereo BioPharma's Debt Ratio came in at 0.07 for Q4 2024, up 15.8% from the prior quarter.

Analysis

Mereo BioPharma (MREO) Debt Ratio (2017 - 2024) Analysis & Trends

Going back to Q4 2017, Mereo BioPharma's Debt Ratio data covers 10 quarters.

  • Going back by year, Debt Ratio was 0.17 in FY2022.
  • The five-year range for quarterly Debt Ratio is 0.05 (Q2 2024) to 0.25 (Q2 2020).
  • Business Quant data shows MREO's Debt Ratio at 0.06 (Q3 2024), 0.05 (Q2 2024) and 0.08 (Q1 2024) in the three quarters before Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Mereo BioPharma 46.45 Mn -103.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 0.07
Sep 30, 2024 0.06
Jun 30, 2024 0.05
Mar 31, 2024 0.08
Dec 31, 2022 0.17
Jun 30, 2020 0.25
Dec 31, 2019 0.24
Jun 30, 2019 0.18
Dec 31, 2018 0.32
Dec 31, 2017 0.22
API Access

Mereo BioPharma Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=MREO&period=max&api_key=YOUR_API_KEY